6DF4
TAF1-BD2 in complex with Cpd8 (6-(but-3-en-1-yl)-4-(3-(morpholine-4-carbonyl)phenyl)-1,6-dihydro-7H-pyrrolo[2,3-c]pyridin-7-one)
Summary for 6DF4
Entry DOI | 10.2210/pdb6df4/pdb |
Descriptor | Transcription initiation factor TFIID subunit, 6-(but-3-en-1-yl)-4-[3-(morpholine-4-carbonyl)phenyl]-1,6-dihydro-7H-pyrrolo[2,3-c]pyridin-7-one (3 entities in total) |
Functional Keywords | taf1-bd2, bromodomain, small molecule inhibitor, sbdd, transcription-inhibitor complex, transcription/inhibitor |
Biological source | Oryctolagus cuniculus (Rabbit) |
Total number of polymer chains | 1 |
Total formula weight | 19679.98 |
Authors | Murray, J.M.,Tang, Y. (deposition date: 2018-05-14, release date: 2018-10-31, Last modification date: 2023-10-11) |
Primary citation | Wang, S.,Tsui, V.,Crawford, T.D.,Audia, J.E.,Burdick, D.J.,Beresini, M.H.,Cote, A.,Cummings, R.,Duplessis, M.,Flynn, E.M.,Hewitt, M.C.,Huang, H.R.,Jayaram, H.,Jiang, Y.,Joshi, S.,Murray, J.,Nasveschuk, C.G.,Pardo, E.,Poy, F.,Romero, F.A.,Tang, Y.,Taylor, A.M.,Wang, J.,Xu, Z.,Zawadzke, L.E.,Zhu, X.,Albrecht, B.K.,Magnuson, S.R.,Bellon, S.,Cochran, A.G. GNE-371, a Potent and Selective Chemical Probe for the Second Bromodomains of Human Transcription-Initiation-Factor TFIID Subunit 1 and Transcription-Initiation-Factor TFIID Subunit 1-like. J. Med. Chem., 61:9301-9315, 2018 Cited by PubMed Abstract: The biological functions of the dual bromodomains of human transcription-initiation-factor TFIID subunit 1 (TAF1(1,2)) remain unknown, although TAF1 has been identified as a potential target for oncology research. Here, we describe the discovery of a potent and selective in vitro tool compound for TAF1(2), starting from a previously reported lead. A cocrystal structure of lead compound 2 bound to TAF1(2) enabled structure-based design and structure-activity-relationship studies that ultimately led to our in vitro tool compound, 27 (GNE-371). Compound 27 binds TAF1(2) with an IC of 10 nM while maintaining excellent selectivity over other bromodomain-family members. Compound 27 is also active in a cellular-TAF1(2) target-engagement assay (IC = 38 nM) and exhibits antiproliferative synergy with the BET inhibitor JQ1, suggesting engagement of endogenous TAF1 by 27 and further supporting the use of 27 in mechanistic and target-validation studies. PubMed: 30289257DOI: 10.1021/acs.jmedchem.8b01225 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.3 Å) |
Structure validation
Download full validation report
